Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Blog posts about
 
< Previous 1 2 3 Next >
Data Announced On Bydureon
September 13, 2011
Alkermes, Inc. (NASDAQ:ALKS), Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and Eli Lilly and Company (NYSE:LLY) recently announced new analyses of data from the DURATION 3 and DURATION 4 trials which... Read More
category AMLN , ALKS , External Research , and 7 more.
from DailyMarkets.com
(ALKS) Alkermes Analyst Maintains Neutral Rating on Shares
September 01, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (ALKS). Alkermes is a drug delivery... Visit StockBlogHub to view complete post. Read More
category Glaxosmithkline plc , ALKS , Johnson & Johnson , and 15 more.
from Stock Blog Hub
Risk Reward Balances Alkermes
August 31, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (NASDAQ:ALKS). Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery technologies to develop... Read More
category AMLN , ALKS , External Research , and 6 more.
from DailyMarkets.com
Wall Street Analyst Actions 08-23-11
August 23, 2011
category Analyst/Actions
from Wall Street Greek
Up/Downgrades (AET, ALKS, CNP, CYN, COH, HWAY, JNPR, LNN, NRG, PWRD, SAFM, HRL, LNCR, PEG, STP)
August 23, 2011
New York, August 23rd (TradersHuddle.com) – Following are some of the top upgrades and downgrades before the market open. Upgrades Aetna (<a href="http://www.trad. Read More -- Read More
from TradersHuddle.com
Revenues Rise At Elan
July 29, 2011
Elan Corporation’s (NYSE:ELN) loss per share of 2 cents (excluding special items) for the second quarter of 2011 was narrower than the Zacks Consensus Estimate loss of 3 cents. The company suffered an... Read More
category ELN , ALKS , Stocks , and 3 more.
from DailyMarkets.com
(AMLN) Amylin Pharmaceuticals Loss Narrows on Lower Costs
July 28, 2011
Amylin Pharmaceuticals (AMLN) reported a net loss of 21 cents per share in the second quarter of... Visit StockBlogHub to view complete post. Read More
category AMLN , Biotechnology , ALKS , and 9 more.
from Stock Blog Hub
Eli Lilly Misses OnEPS, Beats On Sales
July 21, 2011
Eli Lilly & Company (NYSE:LLY) reported second quarter adjusted earnings per share of $1.18, a penny below the Zacks Consensus Estimate and 6 cents below the year-ago earnings of $1.24. Earnings were... Read More
category AMLN , ALKS , wmt , and 4 more.
from DailyMarkets.com
Alkermes’ Fiscal 2012 Guidance
July 20, 2011
Alkermes, Inc. (NASDAQ:ALKS) provided revenue guidance for fiscal 2012 (ending March 31, 2012) taking into account its impending merger with Elan Corporation’s (NYSE:ELN) drug delivery unit – Elan Drug... Read More
category AMLN , ELN , ALKS , and 4 more.
from DailyMarkets.com
Earnings Preview: Eli Lilly
July 14, 2011
Eli Lilly & Company (NYSE:LLY) is all set to announce its second quarter 2011 results on July 21, 2011 before the opening bell. The Zacks Consensus Estimate for the second quarter is $1.17,... Read More
category ALKS , Stocks , External Research , and 2 more.
from DailyMarkets.com
Update On Amylin’s Bydureon
July 11, 2011
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and its partners, Eli Lilly and Company (NYSE:LLY), and Alkermes, Inc. (NASDAQ:ALKS), recently presented results from a thorough QT (tQT) study with... Read More
category AMLN , ALKS , Stocks , and 3 more.
from DailyMarkets.com
(NVO) Novo Nordisk Presents Late Stage Degludec Data
July 05, 2011
Recently, Novo Nordisk (NVO) presented data from late stage trials, which showed that its ultra-long acting insulin Degludec lowered blood glucose levels with significantly reduced risk of hypoglycemia... Read More
category AMLN , ALKS , Sanofi/Aventis , and 9 more.
from Stock Blog Hub
(ALKS) Alkermes Presents Encouraging Data
July 01, 2011
Recently, Alkermes Inc. (ALKS) presented encouraging top line data from an early stage study of its schizophrenia candidate ALKS 9070 (n=32). ALKS 9070 is a once-monthly injectable extended release... Read More
category AMLN , ELN , ALKS , and 9 more.
from Stock Blog Hub
NVO Presents Degludec Data
July 01, 2011
Recently, Novo Nordisk (NYSE:NVO) presented data from late stage trials, which showed that its ultra-long acting insulin Degludec lowered blood glucose levels with significantly reduced risk of... Read More
category AMLN , ALKS , External Research , and 5 more.
from DailyMarkets.com
Encouraging Data Presented By ALKS
July 01, 2011
Recently, Alkermes Inc. (NASDAQ:ALKS) presented encouraging top line data from an early stage study of its schizophrenia candidate ALKS 9070 (n=32).  ALKS 9070 is a once-monthly injectable extended... Read More
category AMLN , ELN , ALKS , and 5 more.
from DailyMarkets.com
(NVO) Novo Nordisk Presents Diabetes Study Data
June 29, 2011
Recently, Novo Nordisk (NVO) presented data from two extension studies of its lead diabetes drug Victoza at the American Diabetes Association. Victoza is currently marketed as a once-daily human... Read More
category AMLN , ALKS , Drug Manufacturers / Other , and 9 more.
from Stock Blog Hub
(ALKS) Alkermes Evenly Poised
June 24, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (ALKS) with a target price of $18.00. Alkermes is a drug delivery biotech company which uses its proprietary specialized drug delivery... Read More
category AMLN , ELN , JNJ , and 11 more.
from Stock Blog Hub
Alkermes Evenly Poised
June 23, 2011
We are maintaining our Neutral recommendation on Alkermes, Inc. (NASDAQ:ALKS) with a target price of $18.00. Alkermes is a drug delivery biotech company which uses its proprietary specialized drug... Read More
category AMLN , ELN , ALKS , and 5 more.
from DailyMarkets.com
(AMLN) Amylin Pharmaceuticals, Partners Eli Lilly and Alkermes Learn Bydureon Gains EU Approval
June 22, 2011
Amylin Pharmaceuticals, Inc. (AMLN) and its partners, Eli Lilly and Company (LLY), and Alkermes, Inc. (ALKS), recently received a boost with the European Commission granting marketing authorization to... Read More
category AMLN , Biotechnology , ALKS , and 9 more.
from Stock Blog Hub
Bydureon Gains EU Approval
June 22, 2011
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) and its partners, Eli Lilly and Company (NYSE:LLY), and Alkermes, Inc. (NASDAQ:ALKS), recently received a boost with the European Commission granting... Read More
category AMLN , ALKS , Stocks , and 4 more.
from DailyMarkets.com
Alkermes Intros Study On Depression
June 17, 2011
Alkermes Inc. (NASDAQ:ALKS) announced initiation of an early-stage study of pipeline candidate ALKS-5461 for treating patients suffering from treatment-resistant depression (TRD). ALKS-5461 is a... Read More
category ELN , ALKS , Stocks , and 2 more.
from DailyMarkets.com
Promising J&J Pharma Pipeline
May 27, 2011
Johnson & Johnson (NYSE:JNJ) recently provided an update on its Pharmaceuticals business. Since its last Pharmaceuticals business review in 2009, the company gained approval for six new drugs and has... Read More
category jnj , ALKS , Stocks , and 4 more.
from DailyMarkets.com
Most Popular Stocks Right Now on 5/16/11- CNOZ, MBYL, ALKS, BAC, DANR, PRM, HPNN, LOW, BRP, PSP, WNWG
May 16, 2011
Cono Italiano Inc. (CNOZ) is trading at a price of $0.0250, a dramatic change of +0.0050 with % change of 25.00% from its previous day’s close. Currently, the company has a Market capitalization (total... Read More
category PRIMEDIA Inc/ , MBYL , Business , and 20 more.
from CEOWORLD Magazine
Definitive Down Day
May 13, 2011
The stock market indices had a definitive down day today with an opening drop early on cracking support. They then snapped back sharply, failed at resistance, and then rolled over very hard, taking the... Read More
from Harry's Hotline by Harry Boxer
(ALKS) Stock Market News for May 10, 2011 – Market News
May 10, 2011
After suffering a slump last week, commodities made a strong comeback yesterday and lifted the benchmarks higher. Energy shares joined in on the uptrend as crude prices once again rose above $100 per... Read More
category Holly Corporation , MRO , Marathon Oil Corporation , and 27 more.
from Stock Blog Hub
Market Upgrades on 5/10/11- HEOP, KNDL, KWK, LPX, MR, ROSE, SAM, SKS, VIA.B, ALKS, BAP, COLB, CPN, FE, GBL, GTXI
May 10, 2011
Raymond James upgraded shares of Heritage Oaks Bancorp (HEOP), a holding company for Heritage Oaks Bank (the Bank) from an “underperform” rating to a “market perform” rating. Raymond James upgraded... Read More
category Kendle International , ALKS , BAP , and 30 more.
from CEOWORLD Magazine
(ALKS) Alkermesto Buy Elan Unit for $960 Million
May 09, 2011
Recently, Alkermes, Inc. (ALKS) inked a deal with Elan Corporation (ELN) to buy the latter’s Elan Drug Technologies (EDT) segment. The EDT segment is the drug delivery unit of Elan. The merger,... Read More
category ELN , MS , Morgan Stanley , and 11 more.
from Stock Blog Hub
ALKS To Buy Elan Unit For $960M
May 09, 2011
Recently, Alkermes, Inc. (NASDAQ:ALKS) inked a deal with Elan Corporation (NYSE:ELN) to buy the latter’s Elan Drug Technologies (EDT) segment. The EDT segment is the drug delivery unit of Elan. The... Read More
category ELN , MS , ALKS , and 8 more.
from DailyMarkets.com
Market updates: Greece, Chubu Electric, Munich Re, BARC, LLOY, CNA, TCG, ISAT, SRP, ELN, ALKS, VITA, BHP, HBC, LMI
May 09, 2011
BHP Billiton Limited (NYSE:BHP) is trading at a price of $95.50, says company and Australia poised to reap benefits of rebalancing of economic weight to Asia; but short to medium-term challenges... Read More
category NASDAQ:ALKS , HBSA , BCS , and 46 more.
from CEOWORLD Magazine
(AMLN) Amylin Pharmaceuticals Reports Earnings Loss In-Line with Estimates
April 20, 2011
Amylin Pharmaceuticals (AMLN) reported a net loss of 24 cents per share in the first quarter of 2011, in line with the Zacks Consensus Estimate and 3 cents below the year-ago loss of 27 cents. Despite... Read More
category AMLN , Biotechnology , ALKS , and 9 more.
from Stock Blog Hub
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here